Senate Bill 73
116th Congress(2019-2020)
End Taxpayer Subsidies for Drug Ads Act
Introduced
Introduced in Senate on Jan 10, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
73
Congress
116
Policy Area
Taxation
Taxation
Primary focus of measure is all aspects of income, excise, property, inheritance, and employment taxes; tax administration and collection. Measures concerning state and local finance may fall under Economics and Public Finance policy area.
No Senate votes have been held for this bill.
Summary
End Taxpayer Subsidies for Drug Ads Act
This bill prohibits tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs.
"Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is (1) in regard to the drug product, and (2) primarily targeted to the general public.
January 10, 2019
01/10/2019
Read twice and referred to the Committee on Finance.
01/10/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 1:49:19 PM